|
HS Code |
874646 |
| Product Name | DL-Homocysteinethiolactone Hydrochloride |
| Chemical Formula | C4H9NO2S · HCl |
| Molecular Weight | 171.65 g/mol |
| Cas Number | 6038-19-3 |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Melting Point | 139-143°C (decomposes) |
| Storage Temperature | 2-8°C (refrigerated) |
| Purity | Typically ≥98% |
| Synonyms | DL-Homocysteine thiolactone hydrochloride |
| Inchi Key | RZZPDHMUTNYVGM-UHFFFAOYSA-N |
| Pubchem Cid | 122263 |
| Canonical Smiles | C[C@@H](CSC(=O)N)N.Cl |
| Usage | Laboratory research, biochemical studies |
| Hazard Statements | Irritant |
As an accredited DL-Homocysteinethiolactone Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 5-gram amber glass bottle with a secure screw cap, clearly labeled “DL-Homocysteinethiolactone Hydrochloride.” |
| Shipping | **Shipping Description:** DL-Homocysteinethiolactone Hydrochloride is shipped in tightly sealed, chemical-resistant containers to prevent moisture and air exposure. The package is clearly labeled and handled as a hazardous laboratory chemical. During transit, it is kept at ambient temperature, following all relevant safety and regulatory guidelines for chemical shipments. |
| Storage | DL-Homocysteinethiolactone Hydrochloride should be stored in a tightly sealed container, protected from light and moisture. It should be kept at 2–8°C (refrigerated conditions). Avoid exposure to air and incompatible substances such as strong oxidizing agents. Store in a well-ventilated, dry area and clearly labeled to prevent accidental misuse. Follow appropriate regulatory and safety guidelines for hazardous chemicals. |
Applications of DL-Homocysteinethiolactone Hydrochloride in Industrial ManufacturingDL-Homocysteinethiolactone Hydrochloride serves specialized roles in manufacturing sectors involving pharmaceutical synthesis, advanced biomolecule modification, and biochemical reagent production. As a direct manufacturer, we support downstream industries with compliant, specification-driven raw materials, up-to-date documentation, and full process integration expertise. 1. Active Pharmaceutical Ingredient (API) Synthesis for Cardiovascular DrugsDL-Homocysteinethiolactone Hydrochloride is a critical intermediate for the synthesis of APIs targeting homocysteine metabolism modulation in cardiovascular drug formulations, particularly in therapies related to hyperhomocysteinemia. Downstream, manufacturers employ this intermediate during multi-step organic synthesis, where strict purity and traceability requirements apply. The material's introduction typically occurs at the stage involving thiolactone ring opening, subsequently contributing to final molecular assembly steps prior to crystallization and purification. Product consistency and batch reproducibility depend highly on the source material quality and compliance with regulated impurity profiles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Amino Acid Derivative Production for Biochemical ResearchResearch reagent producers utilize DL-Homocysteinethiolactone Hydrochloride to synthesize stable-labeled amino acid derivatives for enzyme mechanism studies and metabolic pathway investigation. This material enters downstream routes involving N-acylation, methylation, or isotopic substitution, forming reference compounds essential for quantitative bioanalytical methods. Controlled batch handling minimizes racemization and supports critical analytical outcome reproducibility required by academic and industrial R&D labs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Bioconjugation Reagent Synthesis for Protein LabelingManufacturers of protein modification reagents employ DL-Homocysteinethiolactone Hydrochloride as a thiol source for selective cysteine residue labeling protocols. It participates in downstream chemical transformations generating reactive intermediates, which then couple to proteins, enzymes, or antibodies in biopharmaceutical development. Correct stoichiometry and controlled reaction conditions are essential to avoid undesired side reactions, enabling precise introduction of functional groups for analytical or therapeutic purposes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis for Sulfur-Containing LigandsFine chemical companies leverage DL-Homocysteinethiolactone Hydrochloride for the synthesis of specialty sulfur-containing ligands applied in catalyst development and advanced material formulations. The thiolactone functionality allows precise ring-opening or functional group transfer, forming chelating ligands with defined stereochemistry and controlled sulfur content. Production lots require stringent in-process analytics for completeness of conversion and trace sulfur quantification, ensuring that the downstream catalysts or materials meet critical performance benchmarks in end-use sectors such as electronics or polymer modification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive DL-Homocysteinethiolactone Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical producer with decades of experience under our belts, every substance we develop impacts both our industry partners and scientific progress. Among our specialty chemicals, DL-Homocysteinethiolactone Hydrochloride stands out due to its distinctive role in research and advanced synthesis. We have learned a lot about it from countless production batches, process optimizations, and feedback loops with partners in biotech, pharma, and academic settings. Producing this compound requires meticulous attention to detail and a steady hand throughout synthesis, isolation, and refinement.
We manufacture DL-Homocysteinethiolactone Hydrochloride at high purity, offering a substance with consistent quality batch after batch. The organic white to off-white crystalline form is not just about aesthetics—freedom from visible impurities often signals quality inside the flask and out. Our team relies on both modern instrumental analyses and practical know-how to ensure tight control over parameters such as moisture content, pH, and trace contaminants. Each lot undergoes rigorous identity testing: NMR, IR, and HPLC spectra are cross-referenced to authentic samples and historical baselines in order to catch any deviations before the material leaves our facility.
Our standard product typically lands at a purity exceeding 98%, with consistent melting range and minimal inorganic residues detectable by ion chromatography or classical methods. It's these details that keep quality managers, researchers, and process chemists coming back with new ideas or projects. We’ve learned customers operating at the cutting edge simply cannot compromise on reliability.
While the name might seem complex, the real story rests in its unique properties compared to generic thiolactones or simple amino acids. This lactone delivers an activated form of homocysteine, which behaves differently from the free amino acid in both laboratory and process environments. The hydrochloride salt ensures greater stability during storage—a real advantage over the free base, which is more prone to oxidation, caking, and spoilage. After hearing client stories about lost batches and decomposition, we invested in optimizing this salt form, and those efforts paid dividends in stability and downstream success.
The choice of DL over L or D forms brings additional advantages for exploratory synthesis and screening. In many applications, the racemic mixture offers broader reactivity and compatibility while maintaining lower cost. Our researchers and customers have pointed out that for upstream work or structural studies, the presence of both isomers helps to quickly identify promising directions without the added expense of single-enantiomer starting materials.
DL-Homocysteinethiolactone Hydrochloride finds its roots in demanding research labs and industrial setups. One of the key drivers remains its central role in probing homocysteine metabolism, which connects to cardiovascular and neurodegenerative disease research. Biochemists rely on its reactivity to generate homocysteine in situ, examine enzyme selectivity, or build stable reference materials. By starting with the thiolactone, researchers access a reactive building block that behaves predictably in open systems. We have supplied this product to teams developing both diagnostic methodologies and mechanistic studies, who need assurance about material identity and the absence of side contaminants that could interfere with trace-level analyses.
This compound also lends itself to organic synthesis as a precursor to tailored thiol-containing molecules. Many pharmaceuticals and specialty reagents demand the accurate incorporation of free thiol groups and specific methylene arrangements. Starting from our DL-Homocysteinethiolactone Hydrochloride, chemists have prepared peptide mimetics, protected amino acid derivatives, and even radiolabeled tracers for advanced imaging. Every synthesis route brings a new set of technical challenges: protecting groups, reaction temperature windows, and purification hurdles. Over the years, our dialogue with synthetic chemists has improved not just our offering, but helped shape emerging techniques in peptide science and molecular diagnostics.
Another growing field is material science. Novel sensor coatings, surface modifiers, and functional polymers often incorporate homocysteinyl moieties. Direct input from researchers led us to tailor lot sizes and packaging formats that fit their workflows, reducing wastage and simplifying transitions from laboratory scale to pilot runs. These practical enhancements draw not only on analytical specs but on our own process engineering experience—knowing firsthand what it means to deal with static-sensitive powders or moisture-dependent yields.
Over the years, we’ve seen the hidden costs of variability, especially in delicate compounds like DL-Homocysteinethiolactone Hydrochloride. Early batches sometimes suffered from trace oxidants or residual solvents, leading to stalled reactions or ambiguous research results at customer sites. We took these lessons to heart, revising solvents systems and paying extra attention to packing conditions. The production crew learned to assess atmospheric oxygen and water levels throughout synthesis and post-purification handling. These small changes have meant fewer complaints, rejections, and—most importantly—research breakthroughs from our clients.
Each lot is handled by a team familiar with the material’s idiosyncrasies. For instance, packing this product in airtight, light-protective containers prevents unnecessary loss or pH drift. Using only virgin packaging, with documented inert liners, ensures nothing foreign touches this sensitive solid. These physical details echo throughout the supply chain: simple details like lot traceability, chain of custody, and batch-to-batch reproducibility have built trust with some of the most demanding customers in science and technology.
Many suppliers offer generic homocysteine or basic amino acid analogues, but few invest in the extra process controls to produce the thiolactone salt at the purities required for advanced use. Customers sometimes ask about switching to cheaper alternatives, but our data shows that off-specification lots or knockoffs introduce variability that ends up costing more in troubleshooting, rework, or regulatory headaches. Through our lab partnerships, we’ve measured unwanted byproducts and inconsistent reactivity in competitive offerings. In some extreme cases, residual acids or unreacted starting materials have sabotaged crucial enzyme studies or caused unexpected chromatographic artifacts.
Free forms of homocysteine remain more sensitive to environmental stresses. Over time, storage and handling can lead to self-oxidized tars, which are visible but sometimes only show up after repeated analytical runs. Because each research application brings distinct purity, stability, and scale-up demands, the DL-Homocysteinethiolactone Hydrochloride hydrochloride salt fits a niche where anything less leads to lost effort or even misleading conclusions.
We have explored process improvements alongside industry experts, from lyophilization tweaks for maximum recovery to the adoption of non-traditional purification media that minimize residual ion loads. Our staff understands the difference that a percent or two in purity, or a subtle color shift, can make to published findings or pilot-scale output. Many teams have come back to us after trying cheaper or non-specialized alternatives—each time reporting setbacks they avoided with our primary product.
Producing and supplying this specialty compound places us at the intersection of analytical chemistry, scale-up, and regulatory compliance. We have direct discussions with quality managers who run projects under GMP or ISO frameworks and who demand complete transparency into our raw materials, processing steps, and supporting documentation. Everything from COA layout design to post-delivery follow-up is shaped by the realities of regulated industries and grant-funded research. When a client builds a project around our material, we provide storage recommendations based on our accelerated aging trials and anecdotal reports from bench chemists—this reduces risk of spoilage and avoids unnecessary batch retesting.
Our teams routinely audit key steps, from raw materials assessment to batch homogeneity checks using both classical bench assays and high-throughput analytical platforms. We offer reproducibility data that stretches across multiple production years. This approach, not just a set of paper assurances, has led to collaborative troubleshooting with our network when issues arise, whether it's sensitivity in a particular bioassay or unexpected crystallization issues in a new dissolution medium.
Our daily experience with DL-Homocysteinethiolactone Hydrochloride brings a front-row seat to questions about process sustainability and responsible chemical stewardship. Strong sulfur-containing intermediates can pose odor and effluent concerns, so we’ve adapted our venting and waste neutralization steps to minimize environmental footprint and community impact. Our facility runs on a closed-process logic, capturing off-gassing and recycling solvent streams where feasible. Over the last several cycles, process engineers found ways to reduce waste load per kilo of product, leading to measurable reductions in both costs and environmental impact.
Staff training covers not only technical proficiency but awareness of environmental and safety best practices. Every incremental improvement pays forward across the supply chain, and we remain committed to ongoing transparency with our partners about what’s in—and what’s not in—our product.
Technical feedback drives progress in a specialty plant like ours. We actively solicit suggestions and incident reports from downstream users, incorporating this information into both batch notes and the next cycle of process optimization. Years ago, changes in research protocols at major pharma labs highlighted the need for a finer particle size and lower chloride content. Responding to these requirements led us to trial new filtration and recrystallization techniques. These changes not only satisfied those partners but also raised the standard for all subsequent output.
We maintain an open channel with academic labs tackling non-traditional applications, from epigenetic fingerprinting to rare-element chelation chemistry. Many of our improvements originated in these settings, with motivated grad students or PI’s bringing defects and ideas to our attention. Rather than merely dismissing off-label uses, we document outcomes, incorporate safe handling notes, and feed validated findings into both product sheets and future production cycles.
From our perspective, every gram exported shapes the scientific record. This shapes our philosophy in handling documentation, validations, and lot reproducibility standards. We partner with customers to disclose complete impurity profiles, offering open data on minor component levels and storage stability outcomes. A handful of collaborations have led us to adopt advanced analytical standards, such as quantitative MS fingerprinting and headspace GC for trace volatiles, which few global producers currently provide.
Our commitment to scientific transparency is bolstered by a field-tested track record of error resolution and post-sale support. A customer can pick up the phone and speak directly with a veteran production manager about any inconsistency. We’ve replaced batches, run side-by-side requalifications, and issued corrective actions on the rare occasion a complaint arises. These real-world measures strengthen supply chain integrity and protect the scientific value downstream users deliver.
As market and research demands evolve, so does our offering of DL-Homocysteinethiolactone Hydrochloride. Increasing emphasis on metabolic disorder studies, peptide engineering, and next-generation sensor development calls for a supply partner ready to adapt quickly. Our team monitors academic and industrial trends, holding regular roundtables to review emerging applications or technical requirements. A few years ago, growing interest in alternative reducing agents prompted us to benchmark our processes for sulfur purity and residual reducing sugars, resulting in tighter internal controls.
We pay close attention to regulatory concerns, including questions on supply chain transparency, residual allergens, and trace impurity controls. A collaborative project with a biotech firm led to the implementation of additional screening for genotoxic impurities—years ahead of formal regulatory requirements. These steps may seem small in daily practice but amount to substantial risk reduction for everyone involved, from bench scientist to end patient.
For us, DL-Homocysteinethiolactone Hydrochloride is not just another item on a catalog list. It represents both technical achievement and an ongoing promise to support our partners in reaching ambitious goals. Ethically, we have a responsibility to back every lot with data, experience, and direct dialogue that addresses the needs on the ground, not just compliance on paper. Our facility brings together collective wisdom from chemists, process engineers, and support staff who know the material intimately.
Through constant learning and honest collaboration, we help unlock new paths in medical, analytical, and industrial research. Across countless batches and thousands of kilograms produced, no challenge has edged out our drive to provide reliable, high-quality DL-Homocysteinethiolactone Hydrochloride. The real difference begins where careful production and open partnership meet the rigor of discovery.